|
|
|
|
LEADER |
01853nmm a2200445 u 4500 |
001 |
EB002009373 |
003 |
EBX01000000000000001172272 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
220131 ||| eng |
100 |
1 |
|
|a Matharu, Navneet
|
245 |
0 |
0 |
|a Modulating gene expression to treat diseases
|h Elektronische Ressource
|c Navneet Matharu
|
260 |
|
|
|a London
|b Henry Stewart Talks
|c 2021, 2021
|
300 |
|
|
|a 1 streaming video file (20 min.)
|b color, sound
|
505 |
0 |
|
|a Contents: Programmable DNA targeting modules -- Effector domain functions and possibilities -- Haploinsufficiency and its role in disease -- CRISPRa targeting strategy to rescue Sim1 obesity -- CRISPRa targeting strategy to treat Mc4r haploinsufficiency
|
653 |
|
|
|a Loss of Function Mutation
|
653 |
|
|
|a Clustered Regularly Interspaced Short Palindromic Repeats
|
653 |
|
|
|a Haploinsufficiency
|
653 |
|
|
|a CRISPR-Cas Systems
|
653 |
|
|
|a Obesity / genetics
|
653 |
|
|
|a Genetic Diseases, Inborn / therapy
|
653 |
|
|
|a Gene targeting
|
653 |
|
|
|a Molecular genetics
|
653 |
|
|
|a Gene therapy
|
653 |
|
|
|a Medical genetics
|
653 |
|
|
|a Obesity / therapy
|
653 |
|
|
|a Up-Regulation
|
653 |
|
|
|a CRISPR (Genetics)
|
653 |
|
|
|a Gene Expression Regulation
|
653 |
|
|
|a Gene Targeting / methods
|
653 |
|
|
|a Basic Helix-Loop-Helix Transcription Factors
|
653 |
|
|
|a Receptor, Melanocortin, Type 4
|
653 |
|
|
|a Gene expression
|
653 |
|
|
|a Repressor Proteins
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b HST
|a Henry Stewart Talks
|
490 |
0 |
|
|a The biomedical & life sciences collection
|
500 |
|
|
|a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web
|
856 |
4 |
0 |
|u https://hstalks.com/bs/4844
|x Verlag
|z Streaming video file
|
082 |
0 |
|
|a 570
|